StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Pioglitazone Hydrochloride

HCID 60560
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
112529-15-4
Standard-SMILES
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1.Cl
InChIKey
GHUUBYQTCDQWRA-UHFFFAOYSA-N
Summenformel
C19H21ClN2O3S
Durchschnittliche Molmasse
392,9 g/mol
Monoisotopische Masse
392,09614121

Überblick

Pioglitazone hydrochloride is an aromatic ether.

Namen und Bezeichner

Bevorzugter Name
Pioglitazone Hydrochloride
IUPAC
5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride
Englischer Name
Pioglitazone hydrochloride
Summenformel
C19H21ClN2O3S
Molmasse
392.9

Namen und Synonyme

pioglitazone hydrochloride112529-15-4Pioglitazone HClPiomedDiabiomGlidipionGlizofarPioglitazone (as hydrochloride)DTXSID3044203JQT35NPK6CSTR-001Pioglitazonehydrochloride
Weitere Namen anzeigen
ACTOSPioglitazone hydrochlorid[5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloridePiogPiogLAD-4833U-72107ECAS:112529-15-4
NSC-758876DTXCID1024203OSENI COMPONENT PIOGLITAZONE HYDROCHLORIDEPioglitazone.HClRefChem:56526(5RS)-5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione monohydrochloride5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochlorideU-72107A

Datenbank-Bezeichner

CAS
112529-15-4
PubChem CID
60560
DTXSID
DTXSID3044203
ChEMBL
CHEMBL1715
ChEBI
CHEBI:8229
UNII
JQT35NPK6C
EC Number
629-731-9

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
93,6 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
5
Frei drehbare Bindungen
7
Schwere Atome
26
Formalladung
0
Komplexität
466

Experimentelle und physikochemische Eigenschaften

Solubility1.8 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 5 Einträge

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Collision Cross Section178 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
193 · 193-194°C
storage temp.
2 · 2-8°C
Löslichkeit
10 mg/mL · DMSO: ≥10mg/mL
Aggregatzustand
powder
Farbe
white to off-white
Wasserlöslichkeit
Soluble in water (<1 mg/ml at 25°C), DMF, methanol, ethanol (4 mg/ml at 25°C), and DMSO (79 mg/ml at 25°C).
Merck
14 · 14,7452
BCS Class
2 · 2
Stabilität
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H
InChIKey
GHUUBYQTCDQWRA-UHFFFAOYSA-N
SMILES
S1C(CC2=CC=C(OCCC3=NC=C(CC)C=C3)C=C2)C(=O)NC1=O.[H]Cl
CAS Datenbank
112529 · 112529-15-4(CAS DataBase Reference)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (12.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P318, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 57 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 4 (12.3%)

Toxikologische Informationen

Exposure Routes · 1 Eintrag

Following oral administration, in the fasting state, pioglitazone is first measurable in serum within 30 minutes, with peak concentrations observed within 2 hours. Food slightly delays the time to peak serum concentration to 3 to 4 hours, but does not alter the extent of absorption.

Toxicity Summary · 1 Eintrag

Pioglitazone acts as an agonist at peroxisome proliferator activated receptors (PPAR) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR-gamma receptors increases the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In this way, pioglitazone both enhances tissue sensitivity to insulin and reduces hepatic gluconeogenesis. Thus, insulin resistance associated with type 2 diabetes mellitus is improved without an increase in insulin secretion by pancreatic β cells.

Carcinogen Classification2A, probably carcinogenic to humans. (L135)
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Pioglitazone hydrochloride

vLess-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Toxicity DataHypogycemia; LD<sub>50</sub>=mg/kg (orally in rat)

Sicherheitsdaten

wgk
3
hs_code
29341000
risk_code
36/38-36
hazard_code
Xi
safety_code
22-24/25-26
hazard_class
IRRITANT
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 OralCarc. 2

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesHepatic
FDA Pharmacological Classification · 2 Einträge

PIOGLITAZONE HYDROCHLORIDE

Peroxisome Proliferator Receptor gamma Agonist [EPC]; Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]; Peroxisome Proliferator Receptor alpha Agonist [EPC]; Thiazolidinediones [CS]; Thiazolidinedione [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]

MeSH Pharmacological ClassificationSubstances which lower blood glucose levels.

Verwendung und Herstellung

UsesTreatment of Type II diabetes mellitus
Anwendungen · 2 Einträge

BeschreibungPioglitazone is a new orally active thiazolidinedione (TZD) launched in the US for the treatment of non-insulin dependent diabetes mellitus (NIDDM). It can be synthesized in 4 steps, the last one transforming an alphabromoester into thiazolidine with thiourea. As with other representatives in this class, it potently activates the nuclear receptor peroxisome proliferator-activated receptor gamma which is believed to be involved in the regulation of insulin resistance and adipogenesis. In several obese and obese diabetic animal models, treatment with Pioglitazone resulted in reductions in plasma glucose and serum lipids. In clinical studies, Pioglitazone at a once daily oral dose of 15-45 mg, as monotherapy or in combination with non-TZDs or insulin, was shown to significantly improve glycemic control in type-2 diabetes and demonstrated a beneficial effect on insulin resistance and other clinically relevant parameters as plasma levels of triglycerides or HDL-cholesterol. Pioglitazone is reported to be safe and well tolerated and is said to have a lower occurrence of hepatic toxicity as well as a low probability for drug interaction.

VerwendenPioglitazone hydrochloride is a euglycemic agent,used as an antidiabetic.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

MethylacrylatHydrogenbromidNatriummethanolatKupferoxid5-Ethylpyridin-2-ethanolPalladiumdihydroxid1-Fluor-4-nitrobenzolNatriumacetatNatriumhydrid

Nachgelagerte Produkte

Pioglitazone

Zugehörige Reaktionen

9
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 882709
HRID 882709als Edukt
Reaktionsgleichung von HRID 1486412
HRID 1486412als Edukt
Reaktionsgleichung von HRID 1486413
HRID 1486413als Edukt
Reaktionsgleichung von HRID 1486414
HRID 1486414als Edukt
Reaktionsgleichung von HRID 1522800
HRID 1522800als Edukt
Reaktionsgleichung von HRID 2195571
HRID 2195571als Edukt
Reaktionsgleichung von HRID 2195572
HRID 2195572als Edukt
Reaktionsgleichung von HRID 2273588
HRID 2273588als Edukt
ZurückSeite 1 von 2

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung